Stock photo of people commuting on e-bikes and scooters. (Maskot/STOCK PHOTO/Getty Images)
(NEW YORK) — E-bikes and e-scooters led to a growing number of trauma injuries at one New York City hospital, according to a new study published Wednesday.
About 7% of all trauma visits between 2018 and 2023 at Bellevue Hospital Center were due to micromobility injuries. Micromobility is the use of small, lightweight and low-speed modes of transportation such as bicycles, e-bikes and e-scooters.
The study showed a growing share of patients who sustained these injuries had accidents linked to e-bikes or e-scooters.
Hospital data showed that, by 2023, over half of all trauma cases related to bikes or scooters involved an e-bike or e-scooter, an increase from just 8% in 2018, according to the study, published in the journal Neurosurgery.
The most common type of mechanism involved a collision with a motor vehicle followed by falls from the bike or scooter.
Bellevue is a Level 1 Trauma center in a large metropolitan city, designed to treat the worst kinds of injuries. Over the study period, about 30% of patients suffered a traumatic brain injury, 26% had injury to the skull or face and 50% required surgery.
“Our study shows that micromobility injuries are producing serious brain and spinal trauma that demands neurosurgical care at a scale we haven’t seen before,” corresponding study author Dr. Hannah Weiss, a resident in the Department of Neurosurgery at NYU Grossman School of Medicine, said in a press release. “In a busy urban setting, we are seeing more and more of these injuries firsthand.”
Most patients seen for these injuries, nearly 69%, needed to be admitted to the hospital and nearly a third needed intensive care.
The majority of patients stayed at least three days in the hospital. Pedestrians who were struck had higher rates of traumatic brain injuries and were more likely to be admitted for intensive care.
“The data point to actionable solutions — helmet use, safer bike lane design and enforcement — that could prevent many of these injuries and better protect both riders and pedestrians, who in our study often sustained even more severe brain injuries than the riders themselves,” Weiss said.
About 20% of patients were intoxicated with alcohol, only 31% were using a helmet and injuries were more likely to occur in the evening hours, according to the study.
“Our findings make clear that urban infrastructure must continue to improve to keep pace with the rapid rise of electric bikes and scooters,” Dr. Paul P. Huang, an associate professor in the department of neurosurgery at NYU Grossman School of Medicine and chief of neurosurgery at NYC Health + Hospitals/Bellevue, said in a press release.
“Future studies should track these injuries across multiple cities and measure whether protected bike lanes, helmet programs, and speed enforcement actually reduce the number of brain and spine surgeries we perform,” Huang added,
Jade A. Cobern, MD, MPH, is a practicing physician, board-certified in pediatrics and general preventive medicine, and is a fellow of the ABC News Medical Unit.
Signage outside the Center for Disease Control (CDC) headquarters in Atlanta, Georgia, US, on Friday, Dec. 5, 2025. (Megan Varner/Bloomberg via Getty Images)
(NEW YORK) — Cigarette smoking among U.S. adults continues to fall to record low levels as e-cigarette use rises, according to a report from the Centers for Disease Control and Prevention (CDC) published early Thursday.
Nearly 10% of adults in the U.S. smoked cigarettes in 2024, the report found. This is down from about 11% in 2023, CDC data shows.
Rates of cigarette use have dramatically fallen since a landmark 1964 Surgeon General report warned about the dangers of cigarette smoking and linked it to lung cancer, chronic bronchitis and other serious diseases.
The 1964 report also found a 70% higher mortality rate among smokers and helped launch a nationwide anti-smoking campaign.
At the time, more than 42% of adult Americans were smokers, according to the Surgeon General.
“Decreased cigarette use is certainly in line with decades of trends and really hard work on the part of public health and education folks to get the word out about how awful cigarettes are and how deadly they are,” Dr. Maria Rahmandar, medical director of the substance use & prevention program in the division of adolescent and young adult medicine at Ann & Robert H. Lurie Children’s Hospital of Chicago, told ABC News.
“However, with decreased cigarette use, that means that big tobacco companies are losing money, and so they’re always looking for new ways to capture customers and hook new people on powerfully addictive … nicotine,” she added.
The new CDC report found those living in rural areas were more likely to smoke more than city dwellers. More than 15% of those in non-metropolitan areas smoked cigarettes compared to those living in cities, the report noted.
Meanwhile, the report found that 7% of American adults used e-cigarettes, or vapes, in 2024.
This is a slight uptick from 6.5% of adults reporting e-cigarette use in 2023 and nearly double from the 3.7% of adults who reported using e-cigarettes in 2020, CDC data shows.
“I think we had a shot [at] the first tobacco‑free generation prior to e‑cigarettes coming onto the market. Unfortunately, it’s kind of derailed that progress,” Thomas Carr, director of national policy at the American Lung Association, told ABC News.
The report found that vaping patterns were similar to cigarettes by metro areas, where 6.1% reported using e-cigarettes compared to 9.2% in rural areas.
Previous CDC data found that men; those who identify as lesbian, gay or bisexual; and those who report serious psychological distress are more likely to report current e-cigarette use.
The CDC has also previously found that some adults use e-cigarettes to try to quit smoking cigarettes. The health agency notes the Food and Drug Administration has not approved any e-cigarette to help people quit smoking.
Rahmandar said e-cigarettes have been marketed as a way for people to get off cigarettes, which she noted can help. But she cautioned that there are still many unknowns about e-cigarette harms.
“Cigarettes are terrible, and it is possible that e‑cigarettes are safer — not safe — safer than cigarettes,” she said. “So could it be better for somebody to switch that in a harm reduction philosophy? Yes, however, we still don’t know long term effects of e‑cigarettes, either … We know that there are immediate effects. There certainly are harmful chemicals, carcinogens, toxins, heavy metals, respiratory irritants and other things inside of there that certainly can cause immediate harm.”
By age, those between age 45 and 64 were most likely to be smokers followed by those between ages 25 and 44.
Among vapers, those between ages 18 and 24 had the highest prevalence of e-cigarette use followed by those between ages 25 and 44.
Previous CDC data has shown that the majority of young adults who use e-cigarettes have never smoked cigarettes.
“I think this is … the JUUL generation,” Carr said, referencing what was the most popular e-cigarette in the U.S. “From 2017 to 2019, they got teens to get hooked on JUUL, and they’re now adults, and unfortunately, they haven’t been able to quit using e-cigarettes.”
Tiffany Le, MD, is a pediatrics resident at UT Southwestern Medical Center and a member of the ABC News Medical Unit.
ABC News’ Liz Neporent contributed to this report.
Pfizer logo (Photo Illustration by Nikolas Kokovlis/NurPhoto via Getty Images)
(NEW YORK) — Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme disease vaccine showed more than 70% efficacy in late-stage clinical trials.
The candidate, PF-07307405, showed 73.2% efficacy in reducing confirmed cases of Lyme disease cases after the fourth and final dose was administered when compared to a placebo.
However, the companies said there were fewer than anticipated cases of Lyme disease during the trial period and the study missed an important benchmark.
The trial did not reach its primary endpoint to provide an idea of how the results of this vaccine would turn out in a much larger population of people. Only with re-analyzing the data were researchers able to generate a statistically meaningful result.
Experts in tick-borne diseases told ABC News they still need to see the full data from the trials and that it’s early to determine what kind of impact the vaccine will have — but they add that results are “encouraging.”
“There are many other companies that are trying to develop something, but those are years and years and years away from being anywhere close to being marketed,” Dr. Gene Shapiro, a professor of pediatric infectious diseases and epidemiology of microbial diseases, told ABC News. “So, this vaccine was very similar to the vaccine that we know worked in the past. I think we have to pay attention to [this new one].”
Lyme disease is a bacterial infection that is spread through the bite of blacklegged ticks, also known as deer ticks, according to the Centers for Disease Control and Prevention (CDC).
Symptoms include fever, headache, fatigue and a skin rash known as erythema migrans, the CDC says. If left untreated, the infection can spread to joints, the heart and the nervous system.
More than 89,000 cases of Lyme disease were reported to the CDC by state health departments and the District of Columbia in 2023, according to the latest data available from the federal health agency. Estimates suggest about 476,000 Americans may be diagnosed and treated for Lyme disease annually.
Currently, no vaccine for Lyme disease is available in the U.S. Previously, a vaccine was available, but it was discontinued in 2002, according to the CDC.
“The uptake was poor. The sales were poor, and the company decided to stop selling it,” Shapiro said. “The currently developed vaccine [by Pfizer and Valneva] is very, very similar to that vaccine, with very minor modifications.”
Dr. Martin Becker, a clinical associate professor in the department of medicine at NYU Grossman Long Island School of Medicine, added that there were concerns raised, including about vaccine recipients having joint problems but several studies examining a link failed to find an association.
Becker said there have been many clinical trials underway “but this one that Pfizer just announced, I believe, is the one that’s been most advanced,” he told ABC News. “We were eagerly awaiting results from this large Phase III trial. Other previous trials were already published showing the safety and immunogenicity [of the vaccine].”
Pfizer and Valneva said they are planning to file for approval with the U.S. Food and Drug Administration, with Pfizer telling ABC News that the trial results show there is a level of protection against Lyme disease.
“It doesn’t mean it doesn’t work, but it does mean — if we had higher numbers of incidence of infection — we would be more confident about the degree of protection. It’s very encouraging,” Becker said.
Questions remain about whether the vaccine, if approved, will have higher uptake than the previous vaccine did decades earlier.
Shapiro said there might be more uptake with this vaccine if stronger recommendations are made. At the time the old vaccine was approved by federal regulators, Shapiro said the recommendation from the CDC’s Advisory Committee on Immunization Practices was to consider the shot for those at higher risk, but it was not recommended for those at low or no risk.
“It was not a very strong recommendation,” Shapiro said. “And I think there was less awareness of Lyme disease. So, most likely, [the newer vaccine] would get a stronger endorsement today.”
Bottles of children’s ibuprofen, made for Taro Pharmaceuticals U.S.A., Inc., are being recalled due to the potential presence of a foreign substance. (NIH)
(NEW YORK) — Nearly 90,000 bottles of children’s ibuprofen are being voluntarily recalled due to the potential presence of a foreign substance.
According to a notice from the Food and Drug Administration, Taro Pharmaceuticals U.S.A., Inc. received complaints from customers who reported “a gel-like mass and black particles” in the drug products.
Four-ounce (120 ml) bottles of Children’s Ibuprofen Oral Suspension are impacted by the recall. The FDA said the children’s medications, intended for pain relief from the common cold, flu, sore throat, headache and toothache and a fever reducer, were manufactured in India for Taro Pharmaceuticals U.S.A., Inc.
Recalled children’s ibuprofen products have lot codes of: 7261973A and 7261974A and bear an expiration date of 01/31/2027, according to the federal agency.
The FDA is classifying the recall as a Class II, which the agency defines as anything where the “use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
ABC News has reached out to Taro Pharmaceuticals and its parent company Sun Pharma for comment.
The healthcare.gov website on a laptop arranged in Norfolk, Virginia, US, on Saturday, Nov. 1, 2025. (Stefani Reynolds/Bloomberg via Getty Images)
(NEW YORK) — When Jessica Chamberlain went to sign up for health insurance coverage under the Affordable Care Act (ACA) for 2026, she not prepared for the sticker shock.
Last year, Chamberlain was paying $59.67 in monthly premiums. This year, she would be paying nearly $100.
The 43-year-old mother of two from Illinois said she was floored to see her monthly premiums were nearly doubling.
“I can’t afford that as a single mom with two kids,” she told ABC News.
After carefully weighing her options, Chamberlain decide to forego health insurance and is currently uninsured.
“What do I sacrifice [to pay for health insurance]? I’m diabetic,” she said. “What do I have to sacrifice to keep my medications and my health afloat?
Chamberlain is not alone. Nearly one in 10 people enrolled in the ACA Marketplace last year dropped their coverage in 2026, according to a new KFF survey published Thursday.
The findings come amid rising health care costs and the end of the enhanced premium tax credits. The tax credits helped lower the cost of monthly premiums for about 22 million Americans covered under the ACA and expired at the end of 2025, with no plans by Congress to extend them.
The survey built upon a previous KFF poll conducted in 2025 among Marketplace enrollees. Surveyors re-interviewed more than 1,100 adults between Feb. 2 and March 2, 2026.
Of the respondents, 69% said they re-enrolled in Marketplace coverage with 39% selecting the same plan and 29% switching plans.
More than half, or 51%, of returning ACA enrollees said their health care costs are “a lot higher” this year compared to last year. Of this group, four in 10 specifically said their premiums are “a lot higher.” Additionally, 80% said all health care costs — including premiums, deductibles, co-pays or coinsurance — are higher.
Meanwhile, 9% of Marketplace enrollees dropped their ACA coverage and are currently uninsured.
When asked why they decided to drop or change their coverage, most respondents said costs were the driving factor.
One of the respondents, Holly Weir, a 26-year-old from Ohio, told ABC News she was paying $30 in monthly premiums last year under a plan run by UnitedHealthcare. This year, her plan went to $177 in monthly premiums.
“I didn’t do anything to pick a new health care plan. I got the bill in the mail and I was like, ‘[Expletive]!'” Weir said. “I didn’t pay too much attention until I got the bill the next month and I was like ‘Oh my God, this isn’t from me going to see a medical provider.'”
Weir decided to cancel her insurance and has applied for Medicaid coverage. She is currently waiting to see if she will be approved.
Weir said she is a thyroid cancer survivor, and she has to see an oncologist every two months or so, in addition to taking regular medication.
“Once that runs out, I’ll get a lot more scared,” she said. “Of course, I’m not going to be stupid and leave it so long. If it does come to it, I’ll pay [for the insurance]. The idea that I would have to spend that each month is frustrating. I’m already not doing amazingly financially.”
The survey found that even those who re-enrolled in the ACA Marketplace may need to rework their household budgets.
More than half, or 55%, said they need to cut spending on food or other basic household expenses to afford their health care costs.
Among those with chronic health conditions, 62% of those who reenrolled in the ACA Marketplace said they will be cutting back on food and other basics.
The survey found that 22% of respondents did not re-enroll in the ACA Marketplace and got coverage through an employer, Medicare, Medicaid or another health plan outside the Marketplace.
Chamberlain, who also responded to the survey, said her kids qualify to be on state-run Medicaid. However, she said she doesn’t qualify because she makes too much in her current role working in probation.
She is hoping she can find another insurance plan to help cover health care costs.
“This is destroying people who have pre-existing conditions,” she said. “It is affecting people, especially single moms. We’re just trying to live.”
The healthcare.gov website on a laptop arranged in Norfolk, Virginia, US, on Saturday, Nov. 1, 2025. (Stefani Reynolds/Bloomberg via Getty Images)
(NEW YORK) — When Jessica Chamberlain went to sign up for health insurance coverage under the Affordable Care Act (ACA) for 2026, she not prepared for the sticker shock.
Last year, Chamberlain was paying $59.67 in monthly premiums. This year, she would be paying nearly $100.
The 43-year-old mother of two from Illinois said she was floored to see her monthly premiums were nearly doubling.
“I can’t afford that as a single mom with two kids,” she told ABC News.
After carefully weighing her options, Chamberlain decide to forego health insurance and is currently uninsured.
“What do I sacrifice [to pay for health insurance]? I’m diabetic,” she said. “What do I have to sacrifice to keep my medications and my health afloat?
Chamberlain is not alone. Nearly one in 10 people enrolled in the ACA Marketplace last year dropped their coverage in 2026, according to a new KFF survey published Thursday.
The findings come amid rising health care costs and the end of the enhanced premium tax credits. The tax credits helped lower the cost of monthly premiums for about 22 million Americans covered under the ACA and expired at the end of 2025, with no plans by Congress to extend them.
The survey built upon a previous KFF poll conducted in 2025 among Marketplace enrollees. Surveyors re-interviewed more than 1,100 adults between Feb. 2 and March 2, 2026.
Of the respondents, 69% said they re-enrolled in Marketplace coverage with 39% selecting the same plan and 29% switching plans.
More than half, or 51%, of returning ACA enrollees said their health care costs are “a lot higher” this year compared to last year. Of this group, four in 10 specifically said their premiums are “a lot higher.” Additionally, 80% said all health care costs — including premiums, deductibles, co-pays or coinsurance — are higher.
Meanwhile, 9% of Marketplace enrollees dropped their ACA coverage and are currently uninsured.
When asked why they decided to drop or change their coverage, most respondents said costs were the driving factor.
One of the respondents, Holly Weir, a 26-year-old from Ohio, told ABC News she was paying $30 in monthly premiums last year under a plan run by UnitedHealthcare. This year, her plan went to $177 in monthly premiums.
“I didn’t do anything to pick a new health care plan. I got the bill in the mail and I was like, ‘[Expletive]!'” Weir said. “I didn’t pay too much attention until I got the bill the next month and I was like ‘Oh my God, this isn’t from me going to see a medical provider.'”
Weir decided to cancel her insurance and has applied for Medicaid coverage. She is currently waiting to see if she will be approved.
Weir said she is a thyroid cancer survivor, and she has to see an oncologist every two months or so, in addition to taking regular medication.
“Once that runs out, I’ll get a lot more scared,” she said. “Of course, I’m not going to be stupid and leave it so long. If it does come to it, I’ll pay [for the insurance]. The idea that I would have to spend that each month is frustrating. I’m already not doing amazingly financially.”
The survey found that even those who re-enrolled in the ACA Marketplace may need to rework their household budgets.
More than half, or 55%, said they need to cut spending on food or other basic household expenses to afford their health care costs.
Among those with chronic health conditions, 62% of those who reenrolled in the ACA Marketplace said they will be cutting back on food and other basics.
The survey found that 22% of respondents did not re-enroll in the ACA Marketplace and got coverage through an employer, Medicare, Medicaid or another health plan outside the Marketplace.
Chamberlain, who also responded to the survey, said her kids qualify to be on state-run Medicaid. However, she said she doesn’t qualify because she makes too much in her current role working in probation.
She is hoping she can find another insurance plan to help cover health care costs.
“This is destroying people who have pre-existing conditions,” she said. “It is affecting people, especially single moms. We’re just trying to live.”
(MASSACHUSETTS) — A Massachusetts judge ruled on Monday in favor of medical organizations in their litigation against Health and Human Services Secretary Robert F. Kennedy Jr. over his changes to federal vaccine policy.
The judge temporarily blocked changes to the childhood vaccine schedule that were made at the beginning of this year, in which Kennedy reduced the number of recommended shots from 17 to 11.
The judge also suspended the appointments of the 13 members of the Centers for Disease Control and Prevention’s vaccine advisory committee, who were all appointed unilaterally by Kennedy after he fired all the preceding members.
This is a developing story. Please check back for updates.
(NEW YORK) — As many as 724,000 service members, their families and veterans may rely on health care at hospitals that face financial vulnerability, partly due to cuts in President Donald Trump’s megabill, according to a new analysis.
The bill, known as HR.1, was signed into law in last summer and included sweeping changes to health care including Medicaid. Strict work requirements, reduced federal funding and tightening provider tax rules impacts hospitals that are dependent on Medicaid, increasing their risk of uncompensated care and reducing revenue.
Service members and their families — many of whom are covered by the military health insurance program TRICARE — rely heavily on civilian hospitals for health care, particularly in areas without military treatment facilities.
The analysis, conducted by researchers the Healthcare Quality and Outcomes Lab at Harvard’s T.H. Chan School of Public Health (HSPH) and first viewed by ABC News, looked at how many TRICARE beneficiaries may be reliant on hospitals considered at risk of financial distress under these new changes.
The researchers said many hospitals rely so heavily on Medicaid reimbursements that cuts to the program under HR.1 will affect care the hospitals provide to other patients, including those in the military community.
“We wanted to get a sense of how many hospitals are potentially at risk for becoming potentially financially unstable with the upcoming looming HR.1 Medicaid cuts,” Dr. Jose Figueroa, co-author of the analysis and associate professor of Health Policy and Management at HPSH told ABC News. “There’s a big focus on rural hospitals, but it is not just rural hospitals at risk, that we were finding that across the country, many urban hospitals are at risk.”
Figueroa said medical services that many TRICARE beneficiaries need are often only offered in civilian hospitals or in civilian health care systems. These beneficiaries are then exposed to hospitals that are potentially at financial risk, he noted.
“Military active duty service members on TRICARE and their families also on TRICARE are increasingly relying on civilian hospitals for their care, even when they’re living within a military base,” Figueroa said. “If we’re finding evidence that there are many hospitals across the country that are at risk, to what extent will that affect military personnel and their families?”
TRICARE is run by the U.S. Department of Defense for those connected to the military, including active duty members, National Guard and reserve members, military retirees and their families. It is not the same as Medicaid, although some may qualify for both.
For their analysis, the team used three different criteria to identify a hospital that might be at risk.
If more than one in four of patients being treated at the hospital are on Medicaid, given that the HR.1. cuts are disproportionally affecting those on the federal health insurance program. If the hospital is a safety net hospital, which serves a large number of patients with no insurance or with Medicaid, or a critical access hospital, which is a rural facility that provides essential health care services to underserved communities. The Altman Z-score, which is an aggregate measure of the financial health of a hospital, combining liquidity, profitability, financial efficiency and solvency measures to categorize a hospital as being at risk for bankruptcy. About 4% of hospitals were considered at higher risk of financial distress — meeting three of the criteria and about 19% were at moderate risk of financial distress — meeting two — according to the analysis.
The team then used a dataset to help to identify 8.9 million TRICARE beneficiaries and their ZIP codes.
The analysis estimated that more than 117,000 TRICARE beneficiaries are currently living on or near military installations potentially exposed to a hospital at higher risk of financial distress. Additionally, more than 607,000 are living near a hospital with a moderate risk of financial distress.
This means that more than 724,000 TRICARE beneficiaries are living in military installation ZIP codes — including bases, camps, posts, depots and stations — where at least one hospital has multiple risk factors for financial distress.
Additionally, more than 3.5 million TRICARE beneficiaries living in ZIP codes without a military installation are potentially exposed to a higher-risk or moderate-risk hospital, the analysis found.
“As a country, we should do our best to take care of the people protecting us,” Figueroa said. “Military personnel and their family members should be protected, and sometimes we have to remind ourselves that drastic cuts to our health care that affect our health delivery system also affects our active military personnel and their families as well.”
Last month, during a Senate hearing, Chief Master Sergeant of the Air Force David Wolfe said troops were struggling to get health care appointments and made reference to issues with TRICARE’s reimbursement rate for providers.
“What we’ve all seen over the length of our careers is a gradual erosion in the availability of that health care for our service members and their families,” Wolfe said, according to the Military Times.
Based on the results of the Harvard analysis, Sen. Elizabeth Warren, D- Mass., is launching an investigation into how the Pentagon is guiding military families through health care cuts and whether Republicans and the Trump administration consulted the Pentagon before the cuts were made, her office told ABC News first.
Warren is also pressing the Pentagon to explain how these cuts are affecting military readiness.
“Donald Trump is putting troops’ lives on the line in the Middle East while ripping away health care from their families at home,” Warren said in a statement to ABC News. “Republicans swore the Medicaid cuts in their Big Beautiful Bill were about cutting waste, fraud, and abuse — is that what they think of our military families’ health care?”
In a statement sent to ABC News, the Pentagon didn’t address Warren’s comments.
“As with all congressional correspondences, the Department will respond directly to the authors as appropriate,” a spokesperson said.
A Pentagon official also said it wouldn’t be appropriate to comment on the methodology of studies not conducted by the department.
The White House didn’t respond to ABC News’ request for comment.
Wyoming Gov. Mark Gordon testifies during the House Natural Resources Committee hearing on Thursday, June 15, 2023. (Tom Williams/CQ-Roll Call, Inc via Getty Images)
(NEW YORK) — Wyoming Gov. Mark Gordon signed a bill into law on Monday banning abortion in the state after a “fetal heartbeat” has been detected.
HB 126, or the Human Heartbeat Act, prohibits abortion once cardiac activity is identified, which is around six weeks of pregnancy, before many women know they’re pregnant.
If cardiac activity is detected, an abortion can only be performed in the case of a medical emergency, meaning if the life of the mother is in danger or if continuing the pregnancy would cause serious or irreversible impairment of a major bodily function, according to the bill.
The bill does not include exceptions for pregnancies as a result of rape or incest.
Any person who intentionally or knowingly violates the act will be charged with a felony punishable by up to five years in prison, a fine of up to $10,000, or both, according to the bill.
“Today I signed the Human Heartbeat Act into law, reaffirming my view that life is sacred. I resoundingly share the determination to defend the lives of unborn children and support the intentions behind the Human Heartbeat Act,” Gordon wrote in a post on X on Monday.
Previously, abortion was allowed in Wyoming until fetal viability, which occurs between 24 and 26 weeks of gestation.
Wyoming is now the fifth state at least to have a “heartbeat ban” following bans enacted in Florida, Georgia, Iowa and South Carolina.
“This ban is an attack on Wyomingites’ constitutional freedom to make their own health care decisions, and it puts the health and well-being of our communities at risk,” Julie Burkhart, president of Wellspring Health Access, Wyoming’s only abortion clinic, said in a statement.
“Every day that this law is in effect means people in our state will face even greater barriers to abortion care — and some may be denied this care altogether,” the statement continued. “With so many across Wyoming already struggling to access reproductive health care, restrictive policies like these take us further in the wrong direction.”
Burkhart said Wellspring Health Access is prepared to challenge the ban in court and will continue to work with regional and national partners to help patients access the care they need.
Gordon wrote in the post on X that he was concerned the bill was “well-intentioned” but would lead to a “fragile legal effort with significant risk of ending in the courts rather than in lasting, durable policy.”
Gordon suggested that voters should decide on the issue and that a question be placed on a ballot asking if an abortion ban should be cemented in the state constitution.
Tylenol (Acetaminophen) tablets are sold in a drugstore in Toronto, Ontario, Canada, on January 17, 2026. (Photo by Creative Touch Imaging Ltd./NurPhoto via Getty Images)
(NEW YORK) — Acetaminophen orders in emergency rooms for pregnant patients fell in the weeks after a White House briefing last year linked its use during pregnancy to an increased risk of autism, a new analysis finds.
Researchers at Harvard and Brown University looked at data from an electronic health records system with more than 294 million patient records from more than 1,600 hospitals and 37,000 clinics across the United States.
They found that orders for acetaminophen, also known by the brand name Tylenol, fell 10% between the briefing on Sept. 22, 2025 and Dec. 7, 2025, according to the analysis, published on Thursday in The Lancet.
The drop in acetaminophen fell 16% in the first month after the White House news conference and reached a low of 20% in the third week after the announcement, according to the analysis. Over subsequent weeks, prescriptions appeared to trend back to baseline by early December.
This analysis did not track over-the-counter use of acetaminophen sales, which is the most common way people purchase the medication.
Meanwhile, as acetaminophen orders fell, new outpatient prescriptions for a drug called leucovorin increased sharply for children between ages 5 and 17, the analysis found.
Leucovorin is a form of folic acid used to reduce side effects from some chemotherapy drugs and treat folate deficiency.
Researchers have also studied it as a possible treatment for some children with autism who have cerebral folate deficiency, but it’s unclear if it has a role in treating children with autism more broadly, according to the American Academy of Pediatrics.
At the same September White House briefing, the Trump administration announced it was starting the approval process for leucovorin as a possible treatment for autism.
Health and Human Services Secretary Robert F. Kennedy Jr. touted the drug as an “exciting therapy that may benefit large numbers of children who suffer from autism.”
The analysis found a 93% rise in leucovorin prescriptions in the first month after the briefing and a 113% spike in week two, meaning prescriptions more than doubled compared with expected levels. Overall, the analysis found that leucovorin prescriptions increased by about 71% from mid-September to early December.
“It is unknown whether the results reported reflect changes in patient demand or clinician decision making; nonetheless, they show the apparent power that public authority figures have to drive sudden changes in health care practices,” the researchers wrote.
Many health professionals and major medical organizations criticized the Trump administration’s assertion that pregnant women should avoid acetaminophen, claiming use during pregnancy may be linked to autism.
Studies on a potential link have not shown a direct cause-and-effect relationship. Some studies point to a possible association, but those associations often weaken or disappear once researchers adjust for other factors.
In January, a large meta-analysis of about 60 studies was published in The Lancet Obstetrics, Gynecology & Women’s Health, finding no link to developmental disorders in children when expectant mothers used acetaminophen as directed.
In response to statements made by the White House, The American College of Obstetrics and Gynecologists (ACOG) strongly rejected the claim that acetaminophen in pregnancy causes autism, calling it “highly concerning,” “irresponsible” and “not backed by the full body of scientific evidence.”
The group emphasized that more than 20 years of research show no direct link between acetaminophen use during pregnancy and autism, attention-deficit/hyperactivity disorder or intellectual disability, specifically pointing to two high-quality studies.
Acetaminophen is regarded as one of the safest non-opioid pain medication for pregnant women, according to ACOG. The group adds it’s an important drug to help treat fever in pregnancy that can have negative health impacts for both mom and baby if left untreated.
“The White House briefing was an extremely unusual mechanism to communicate medical information and bypassed many standard checks on ensuring accurate messaging,” Dr. Michael Barnett, a physician and professor of health services, policy and practice at Brown and one of the researchers, said in a press release.
“The results show just how much political leaders can steer health behavior even when there has been no change in the evidence for these therapies,” Barnett said.
In a statement, Kenvue Brands LLC, the maker of Tylenol, said it was “deeply concerned” about “unfounded claims” over its product.
“It is scientifically known that untreated high fevers pose potential serious risks to a pregnancy, such as miscarriage, pre-term labor and birth, and fetal malformations.” the statement read, in part. ‘As medical organizations have recognized, acetaminophen is the safest option for pain and fever relief for pregnant women as needed throughout their entire pregnancy.”
Kenvue Brands added that there are multiple potential consequences as a result of pregnant women using acetaminophen less frequently, including higher rates of untreated fevers and use of medications that are less safe to use during pregnancy,
“Recent additional evidence has identified no increased rates of autism disorders, attention-deficit hyperactivity disorder, or intellectual disability among the offspring of those who used paracetamol during pregnancy,” the company stated.
Jade A. Cobern, MD, MPH, is a practicing physician, board-certified in pediatrics and general preventive medicine, and is a fellow of the ABC News Medical Unit.
